Author: Rutali Thakur

A claims-based analysis published in Clinical Gastroenterology and Hepatology found that overall cancer incidence was low and comparable across four major classes of advanced IBD therapies. The retrospective study included 15,687 adults with IBD who initiated TNF antagonists, vedolizumab, anti-interleukin therapies or JAK inhibitors between 2016 and 2023. Over a median 2.6 years of follow-up, three-year cumulative cancer incidence was 2.1% with TNF antagonists, 2.7% with vedolizumab, 2.0% with anti-interleukins and 2.5% with JAK inhibitors. After adjustment, none of the three newer therapy classes had a statistically significant difference in cancer risk compared with TNF antagonists. Siddharth Singh, MD, MS,…

Read More

In a new Medical Economics commentary, Robert Resnik, M.D., MBA, a board-certified internal medicine physician who has maintained a private practice for more than 30 years, examines why physician-owned practices are becoming increasingly difficult to sustain. Resnik, who earned his M.D. from Eastern Virginia Medical School and an MBA from Duke University, argues that medical debt, limited business training, administrative burdens, reimbursement pressure and the financial advantages of larger healthcare organizations are pushing physicians toward employment and away from independent ownership. The commentary also points to specialty medicine and rural healthcare, citing declining independent ownership and increasing consolidation. Resnik proposes…

Read More

A new study published in Digestive Diseases and Sciences examined whether the amount of fecal material visible on abdominal CT scans is associated with bowel function and gastrointestinal symptoms. Researchers analyzed 205 adults undergoing CT abdomen/pelvis and compared radiologic fecal burden, measured using the Starreveld scoring method, with patient-reported GI symptoms. Higher total-colon fecal burden showed weak associations with lower stool frequency, fewer liquid bowel movements and greater difficulty evacuating stool. However, fecal burden was not associated with hard stools, urgency, fullness, abdominal discomfort, abdominal pain or nausea. The authors concluded that CT-detected fecal burden is poorly associated with GI…

Read More

Cook Medical has issued a medical device correction for its Hemospray Endoscopic Hemostat, covering the HEMO-7, HEMO-10, HEMO-7-EU and HEMO-10-EU devices across all lots. The correction does not require removal of the devices from the field but updates the Instructions for Use (IFU) with additional preparation steps and precautions related to powder delivery and endoscope adherence. The updated guidance addresses two issues. Hemospray powder can adhere to the distal end of the endoscope, potentially making repositioning or removal difficult, with increased risk when water-based lubricant is used, during retroflexion, or when withdrawing through narrowed anatomy. Powder can also compact during…

Read More

A House Energy and Commerce health subcommittee hearing on Sept. 15 examined the Patients First Act of 2026 and four related bills addressing Medicare physician payment, budget neutrality, MIPS, practice expenses, and healthcare cybersecurity. The Patients First Act would link annual Medicare physician fee schedule updates to inflation through the Medicare Economic Index (MEI), rather than the current fixed updates under MACRA. Starting in 2027, the proposed formula would set updates at MEI minus 1 percentage point for clinicians outside advanced APMs, with qualifying APM participants receiving an additional 0.5 percentage point. The proposals would also modify budget neutrality, including…

Read More

An FDA advisory committee has voted in favor of approving GRAIL’s Galleri multi-cancer early detection (MCED) test, marking a significant regulatory development for blood-based cancer screening. The 10-member Molecular and Clinical Genetics Devices Panel voted 7–2, with one abstention, that the test’s benefits outweigh its risks. The committee voted unanimously in favor of safety and 6–4 in favor of effectiveness. Galleri uses cancer-specific methylation patterns in blood to detect signals from multiple cancer types and predict the likely tissue of origin. It is designed to be used alongside, rather than replace, existing guideline-recommended screening tests. GRAIL says its clinical studies…

Read More

MIT researchers have developed tiny batteries made from biocompatible materials that can safely break down in the gastrointestinal tract after powering ingestible devices. The batteries use magnesium and molybdenum trioxide electrodes and an ionic-liquid gel electrolyte, generating 1.84 volts. They function normally for about three days before gradually degrading and breaking down completely within a few weeks. The researchers demonstrated two applications. One battery powered an ingestible capsule that delivers electrical stimulation to the stomach; in animal testing, 20 minutes of stimulation increased ghrelin levels by about 50%. The technology could potentially support therapies for conditions involving nausea or appetite…

Read More

A new review in Gastroenterology examines the current and emerging treatment landscape for obesity, covering anti-obesity medications, endoscopic bariatric and metabolic therapies, and bariatric surgery. The authors note that while lifestyle therapy alone generally produces modest weight loss, newer pharmacologic, endoscopic, and surgical approaches can produce substantially greater weight loss. The review also focuses on a major implementation challenge: despite the availability of effective therapies, obesity treatment remains limited by cost, inadequate insurance coverage, and insufficient access to clinicians who can prescribe medications or perform endoscopic and surgical procedures. The authors argue that gastroenterologists are particularly well positioned to help…

Read More

Gastroenterology & Hepatology of Central New York is notifying patients about a cybersecurity incident that resulted in unauthorized access to its network and exfiltration of files. The practice identified the incident on March 6, 2026 and engaged cybersecurity and digital forensics specialists to investigate. The affected files contained patients’ names, addresses, phone numbers, dates of birth, Social Security numbers and medical record numbers. Patients were notified on September 17, with complimentary credit monitoring and identity-theft protection offered. The number of affected individuals has not yet been disclosed, and the incident was not listed on the HHS Office for Civil Rights…

Read More

AI adoption in gastroenterology is expanding across clinical decision support, colonoscopy, documentation and evidence review, but gastroenterologists interviewed by Medscape emphasize that implementation needs to keep pace with validation and safeguards. The article highlights Nigel, the AGA’s GI-specific AI assistant, which is built around AGA guidelines and the GRADE evidence framework and was reviewed by GI and liver experts. AI-assisted colonoscopy is another established use case. CADe systems such as GI Genius can highlight potential polyps in real time and have been associated with higher detection of precancerous lesions. However, clinicians raise concerns about deskilling, automation bias, inaccurate or outdated…

Read More